Medacta Corporate
AMISTEM-H awarded ODEP 5A rating

AMISTEM-H awarded ODEP 5A rating

We are proud to announce that AMIStem-H was just awarded the ODEP 5A rating, confirming the promising results of the 3A* score of the last years.

We are proud to announce that AMIStem-H was just awarded the ODEP 5A rating, confirming the promising results of the 3A* score of the last years.

5A ODEP rating means that the AMIStem-H has been evaluated through a multicentric study, with a minimum cohort of 250 hips, demonstrating Kaplan – Meier survivorship data better than, or equal to, 95% at the five year benchmark.

This excellent rating is confirmed and outmatched by a study on AMIStem-H – 5 years preliminary clinical outcomes, performed by the following centres:

  • South West London Elective Orthopaedic Centre, Epsom (UK) - Prof. Richard Field
  • Universitätsklinik Balgrist, Zürich (CH) - Prof. Claudio Dora
  • Northampton General Hospital, Northampton (UK) - Mr. Edward Crawfurd

The study includes 421 patients and the AMIStem-H survival rate at 5 years after surgery resulted in 97.75%, with any reason for revision as endpoint.

 

 Discover AMIStem

 

(ODEP: ORTHOPAEDIC DATA EVALUATION PANEL) 
Latest ODEP ratings can be found at www.odep.org.uk